Aytu Biopharma, Inc.
AYTU
$1.27
$0.010.79%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -46.54% | 131.93% | -59.92% | -1,212.27% | 97.29% |
| Total Depreciation and Amortization | -6.17% | -26.59% | 1.30% | 7.15% | -2.82% |
| Total Amortization of Deferred Charges | 3.70% | -95.48% | -- | -- | 4.05% |
| Total Other Non-Cash Items | 24.55% | -349.92% | 346.31% | -88.87% | -68.10% |
| Change in Net Operating Assets | 510.33% | -1,790.48% | -110.10% | 109.17% | -83.31% |
| Cash from Operations | 344.12% | -51.02% | -210.24% | -88.15% | 36.02% |
| Capital Expenditure | 95.59% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -70.79% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 24.44% | 74.14% | -128.95% |
| Cash from Investing | -61.94% | 1,220.59% | 24.44% | 74.14% | -128.95% |
| Total Debt Issued | -113.76% | -86.43% | 76,644.44% | -- | -- |
| Total Debt Repaid | -0.22% | 97.04% | -3,157.03% | 341.51% | 42.70% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -307.40% | -5.26% | -- | -- | 100.00% |
| Cash from Financing | -402.96% | -14.70% | 101.51% | 520.63% | 95.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 184.31% | -58.54% | 6.49% | 153.10% | 85.60% |
